Cargando…

Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?

BACKGROUND: Patient-reported outcomes (PROs) aid in rheumatoid arthritis (RA) management, but it is not well understood which measures would be most relevant to the rheumatologists for making treatment decisions. METHODS: We recruited rheumatologists nationally to participate in moderated structured...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagpal, Aprajita, O’Beirne, Ronan, Morris, Melanie S., Johnson, Bernadette, Willig, James, Yun, Huifeng, Cherrington, Andrea L., Fraenkel, Liana, Curtis, Jeffrey R., Safford, Monika M., Navarro-Millán, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727422/
https://www.ncbi.nlm.nih.gov/pubmed/31517249
http://dx.doi.org/10.1186/s41927-019-0087-2
_version_ 1783449247990939648
author Jagpal, Aprajita
O’Beirne, Ronan
Morris, Melanie S.
Johnson, Bernadette
Willig, James
Yun, Huifeng
Cherrington, Andrea L.
Fraenkel, Liana
Curtis, Jeffrey R.
Safford, Monika M.
Navarro-Millán, Iris
author_facet Jagpal, Aprajita
O’Beirne, Ronan
Morris, Melanie S.
Johnson, Bernadette
Willig, James
Yun, Huifeng
Cherrington, Andrea L.
Fraenkel, Liana
Curtis, Jeffrey R.
Safford, Monika M.
Navarro-Millán, Iris
author_sort Jagpal, Aprajita
collection PubMed
description BACKGROUND: Patient-reported outcomes (PROs) aid in rheumatoid arthritis (RA) management, but it is not well understood which measures would be most relevant to the rheumatologists for making treatment decisions. METHODS: We recruited rheumatologists nationally to participate in moderated structured group teleconference discussions using the nominal group technique. Participants in each group generated lists of the elements from patient’s history and signs that they use to make treatment recommendations for RA. Each participant then selected the three most important elements from the generated list. The results of each group were then combined and summarized. RESULTS: Twenty-five rheumatologists participated in 4 groups (group size ranged from 4 to 8) and 150 available ranking votes across all groups. The statements generated across the 4 groups were categorized into 13 topics (including symptoms, physical function, comorbidities, social aspects, physical findings, response to treatment, treatment adherence, pain management, side effects, tests, access to care, contraception, and organ involvement), 10 of which received ranking votes. Symptoms received the highest ranking (46% of votes), followed by physical function (16%), and physical findings (13%). Among the unranked topics, social aspects had the highest number of statements (8 statements). CONCLUSION: Rheumatologists highly valued patient-reported RA symptoms and physical function to inform their treatment decisions, even above objective data such as physical findings and test results. These results can guide the selection of validated PRO measures to assess these domains to inform the clinical care of patients with rheumatoid arthritis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41927-019-0087-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6727422
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67274222019-09-12 Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? Jagpal, Aprajita O’Beirne, Ronan Morris, Melanie S. Johnson, Bernadette Willig, James Yun, Huifeng Cherrington, Andrea L. Fraenkel, Liana Curtis, Jeffrey R. Safford, Monika M. Navarro-Millán, Iris BMC Rheumatol Research Article BACKGROUND: Patient-reported outcomes (PROs) aid in rheumatoid arthritis (RA) management, but it is not well understood which measures would be most relevant to the rheumatologists for making treatment decisions. METHODS: We recruited rheumatologists nationally to participate in moderated structured group teleconference discussions using the nominal group technique. Participants in each group generated lists of the elements from patient’s history and signs that they use to make treatment recommendations for RA. Each participant then selected the three most important elements from the generated list. The results of each group were then combined and summarized. RESULTS: Twenty-five rheumatologists participated in 4 groups (group size ranged from 4 to 8) and 150 available ranking votes across all groups. The statements generated across the 4 groups were categorized into 13 topics (including symptoms, physical function, comorbidities, social aspects, physical findings, response to treatment, treatment adherence, pain management, side effects, tests, access to care, contraception, and organ involvement), 10 of which received ranking votes. Symptoms received the highest ranking (46% of votes), followed by physical function (16%), and physical findings (13%). Among the unranked topics, social aspects had the highest number of statements (8 statements). CONCLUSION: Rheumatologists highly valued patient-reported RA symptoms and physical function to inform their treatment decisions, even above objective data such as physical findings and test results. These results can guide the selection of validated PRO measures to assess these domains to inform the clinical care of patients with rheumatoid arthritis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41927-019-0087-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-09-05 /pmc/articles/PMC6727422/ /pubmed/31517249 http://dx.doi.org/10.1186/s41927-019-0087-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jagpal, Aprajita
O’Beirne, Ronan
Morris, Melanie S.
Johnson, Bernadette
Willig, James
Yun, Huifeng
Cherrington, Andrea L.
Fraenkel, Liana
Curtis, Jeffrey R.
Safford, Monika M.
Navarro-Millán, Iris
Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
title Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
title_full Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
title_fullStr Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
title_full_unstemmed Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
title_short Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
title_sort which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727422/
https://www.ncbi.nlm.nih.gov/pubmed/31517249
http://dx.doi.org/10.1186/s41927-019-0087-2
work_keys_str_mv AT jagpalaprajita whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT obeirneronan whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT morrismelanies whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT johnsonbernadette whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT willigjames whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT yunhuifeng whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT cherringtonandreal whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT fraenkelliana whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT curtisjeffreyr whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT saffordmonikam whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis
AT navarromillaniris whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis